These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 7907434
1. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection. Motojima K, Furui J, Kohara N, Izawa K, Kanematsu T, Shiku H. Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434 [Abstract] [Full Text] [Related]
2. C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. Kern JA, Slebos RJ, Top B, Rodenhuis S, Lager D, Robinson RA, Weiner D, Schwartz DA. J Clin Invest; 1994 Feb; 93(2):516-20. PubMed ID: 7906694 [Abstract] [Full Text] [Related]
3. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL, Wu TT, Choi IS, Wang H, Resetkova E, Correa AM, Hofstetter WL, Swisher SG, Ajani JA, Rashid A, Albarracin CT. Cancer; 2007 Feb 15; 109(4):658-67. PubMed ID: 17211865 [Abstract] [Full Text] [Related]
4. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. Yonemura Y, Ninomiya I, Yamaguchi A, Fushida S, Kimura H, Ohoyama S, Miyazaki I, Endou Y, Tanaka M, Sasaki T. Cancer Res; 1991 Feb 01; 51(3):1034-8. PubMed ID: 1670998 [Abstract] [Full Text] [Related]
5. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas. Yi ES, Harclerode D, Gondo M, Stephenson M, Brown RW, Younes M, Cagle PT. Mod Pathol; 1997 Feb 01; 10(2):142-8. PubMed ID: 9127320 [Abstract] [Full Text] [Related]
6. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM. Hepatogastroenterology; 1997 Feb 01; 44(14):604-9. PubMed ID: 9164544 [Abstract] [Full Text] [Related]
7. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Khalifa MA, Mannel RS, Haraway SD, Walker J, Min KW. Gynecol Oncol; 1994 Apr 01; 53(1):84-92. PubMed ID: 7909788 [Abstract] [Full Text] [Related]
8. Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen. Roh JK, Paik S, Chung HC, Yang W, Kim HK, Choi IJ, Kim J, Koh E, Lee KS, Min JS. Gan To Kagaku Ryoho; 1992 Jul 01; 19(8 Suppl):1207-19. PubMed ID: 1355336 [Abstract] [Full Text] [Related]
9. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, Ebihara S, Takeyama I. Laryngoscope; 1992 Aug 01; 102(8):923-7. PubMed ID: 1353853 [Abstract] [Full Text] [Related]
10. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. McCann AH, Dervan PA, O'Regan M, Codd MB, Gullick WJ, Tobin BM, Carney DN. Cancer Res; 1991 Jun 15; 51(12):3296-303. PubMed ID: 1674898 [Abstract] [Full Text] [Related]
11. Expression of p53 protein in gastric carcinomas is not independently prognostic. Motojima K, Furui J, Kohara N, Ito T, Kanematsu T. Surgery; 1994 Nov 15; 116(5):890-5. PubMed ID: 7940194 [Abstract] [Full Text] [Related]
12. Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer. Giai M, Roagna R, Ponzone R, De Bortoli M, Dati C, Sismondi P. Anticancer Res; 1994 Nov 15; 14(3B):1441-50. PubMed ID: 7915096 [Abstract] [Full Text] [Related]
13. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma. Chou YY, Jeng YM, Lee TT, Hu FC, Kao HL, Lin WC, Lai PL, Hu RH, Yuan RH. Ann Surg Oncol; 2007 Oct 15; 14(10):2748-58. PubMed ID: 17680316 [Abstract] [Full Text] [Related]
14. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type. Adachi Y, Yasuda K, Inomata M, Sato K, Shiraishi N, Kitano S. Cancer; 2000 Oct 01; 89(7):1418-24. PubMed ID: 11013353 [Abstract] [Full Text] [Related]
15. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma. Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S. Croat Med J; 2003 Aug 01; 44(4):429-34. PubMed ID: 12950146 [Abstract] [Full Text] [Related]
16. p185neu expression in human lung adenocarcinomas predicts shortened survival. Kern JA, Schwartz DA, Nordberg JE, Weiner DB, Greene MI, Torney L, Robinson RA. Cancer Res; 1990 Aug 15; 50(16):5184-7. PubMed ID: 1974168 [Abstract] [Full Text] [Related]
17. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features. Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ. Hepatogastroenterology; 1997 Aug 15; 44(17):1488-94. PubMed ID: 9356878 [Abstract] [Full Text] [Related]
19. Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer. Lee SE, Chow NH, Chi YC, Tzai TS, Yang WH, Lin SN. Anticancer Res; 1994 Aug 15; 14(3B):1317-24. PubMed ID: 7915094 [Abstract] [Full Text] [Related]
20. ErbB-3 predicts survival in ovarian cancer. Tanner B, Hasenclever D, Stern K, Schormann W, Bezler M, Hermes M, Brulport M, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Steiner E, Sehouli J, Edelmann J, Läuter J, Lessig R, Krishnamurthi K, Ullrich A, Hengstler JG. J Clin Oncol; 2006 Sep 10; 24(26):4317-23. PubMed ID: 16896008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]